1. Home
  2. PRME vs YORW Comparison

PRME vs YORW Comparison

Compare PRME & YORW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.78

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Logo York Water Company (The)

YORW

York Water Company (The)

HOLD

Current Price

$30.61

Market Cap

509.3M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
YORW
Founded
2019
1816
Country
United States
United States
Employees
N/A
104
Industry
Medicinal Chemicals and Botanical Products
Water Supply
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
536.4M
509.3M
IPO Year
2022
1994

Fundamental Metrics

Financial Performance
Metric
PRME
YORW
Price
$3.78
$30.61
Analyst Decision
Buy
Hold
Analyst Count
6
1
Target Price
$7.56
$34.00
AVG Volume (30 Days)
4.1M
183.8K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
3.13%
EPS Growth
18.18
N/A
EPS
N/A
0.33
Revenue
$4,632,000.00
$77,488,000.00
Revenue This Year
$7.06
$11.78
Revenue Next Year
$47.01
$4.95
P/E Ratio
N/A
$91.79
Revenue Growth
55.28
3.37
52 Week Low
$2.67
$28.26
52 Week High
$6.94
$34.30

Technical Indicators

Market Signals
Indicator
PRME
YORW
Relative Strength Index (RSI) 53.63 53.44
Support Level $3.73 $29.52
Resistance Level $3.82 $30.79
Average True Range (ATR) 0.37 0.63
MACD 0.07 -0.02
Stochastic Oscillator 40.72 52.22

Price Performance

Historical Comparison
PRME
YORW

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About YORW York Water Company (The)

The York Water Co is the investor-owned water utility in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. The company also owns and operates three wastewater collection systems and twelve wastewater collection and treatment systems. The company operates within its franchised water and wastewater territory, which covers portions of municipalities within four counties in south-central Pennsylvania. It provides services to diversified, manufacturing such items as fixtures and furniture, electrical machinery, food products, paper, ordnance units, textile products, air conditioning systems, laundry detergent, barbells, and motorcycles.

Share on Social Networks: